Dr Dionysis Papadatos-Pastos is a Consultant Medical Oncologist at University College London Hospitals and serves as the Clinical Lead for Acute Oncology at Princess Alexandra Hospital. He has a specialist interest in the treatment of lung cancer and mesothelioma.

Dr Papadatos-Pastos graduated with First Class honours in Medicine from the University of Athens and earned his PhD in Medical Oncology in 2012. He completed his medical oncology training at Guy's and St Thomas', St George's University Hospitals, and The Royal Marsden. Additionally, he obtained his specialist certificate in Medical Oncology from the Institute of Cancer Research at the University of London.

Dr Papadatos-Pastos has conducted extensive research into prognostic and predictive biomarkers and the combination of immunotherapy drugs with novel compounds. He has participated in numerous drug trials, presented his findings at international conferences, and published in esteemed peer-reviewed journals such as the Journal of Clinical Oncology, Clinical Cancer Research, and the British Journal of Cancer. His contributions to the field have been recognised with the ASCO merit award in 2010.

In his clinical practice, Dr Papadatos-Pastos focuses on the development of novel targeted therapies for lung cancer and the assessment of combinations of immunotherapy drugs with other anti-cancer compounds. He treats a range of conditions including lung cancer, non-small cell lung cancer, small cell lung cancer, and malignant mesothelioma.

Dr Papadatos-Pastos has been with University College London Hospitals since his appointment and continues to advance the field of medical oncology through both his clinical and research efforts.